China Money Network
Login
Join

IDG Capital Backs Shenzhen-Based Biotech Firm Yuce Bio In Series B Round

  • December 10, 2018 — 18:06 CST

This Data Is Locked!

This area is available only to Subscribers.

Shenzhen-based Biotech firm Yuce Biological Technology has completed a series B round led by IDG Capital, as biotech booms in China. The specific amount of... [DATA LOCKED]

UNLOCK DATA

Follow the Money & Subscribe for Access to the Best Data and Intelligence on Chinese Venture Capital Deals

Join

Access Thousands of Data Points to Monitor Chinese Private Equity Deal Movement and Relationships

Already Have an Account?

Login
Related Topics:

Related Data: